Managing Male OAB: Update for the APP Webcast (2025)

CME Available: https://auau.auanet.org/node/43994 © 2025 by the American Urological Association Education and Research, Inc. After participating in this CME activity, participants will be able to: 1. Counsel and treat patients with OAB by incorporating current evidence on its epidemiology, burden and association of OAB in men with BPH. 2. Integrate into practice the principles for diagnosis, counseling and treatment of OAB based on the clinical recommendations from the 2024 AUA/SUFU Guideline including the application of the Guideline to men with OAB associated with BPH. 3. Implement OAB treatment strategies that incorporate evidence-based knowledge and patient centered considerations, including efficacy and side effects of treatment. 4. Differentiate OAB medications based on mechanisms of action, side effects, and contraindications. 5. Evaluate and apply emerging evidence of the association of antimuscarinic medications with cognitive decline, especially in the frail patients with OAB, into clinical decision making. ACKNOWLEDGEMENTS Support provided by an independent educational grant from: Sumitomo Pharma America, Inc.